HomeCompareSCY vs JNJ

SCY vs JNJ: Dividend Comparison 2026

SCY yields 0.45% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SCY wins by $283.00 in total portfolio value
10 years
SCY
SCY
● Live price
0.45%
Share price
$22.11
Annual div
$0.10
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.3K
Annual income
$46.58
Full SCY calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — SCY vs JNJ

📍 SCY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSCYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SCY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SCY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SCY
Annual income on $10K today (after 15% tax)
$38.44/yr
After 10yr DRIP, annual income (after tax)
$39.59/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $664.02/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SCY + JNJ for your $10,000?

SCY: 50%JNJ: 50%
100% JNJ50/50100% SCY
Portfolio after 10yr
$20.2K
Annual income
$437.18/yr
Blended yield
2.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SCY
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SCY buys
0
JNJ buys
0
No recent congressional trades found for SCY or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSCYJNJ
Forward yield0.45%3.36%
Annual dividend / share$0.10$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$20.3K$20.0K
Annual income after 10y$46.58$827.78
Total dividends collected$460.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SCY vs JNJ ($10,000, DRIP)

YearSCY PortfolioSCY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,745$45.23$10,676$355.77+$69.00SCY
2$11,543$45.42$11,407$389.39+$136.00SCY
3$12,396$45.60$12,198$426.53+$198.00SCY
4$13,310$45.77$13,056$467.62+$254.00SCY
5$14,288$45.93$13,987$513.12+$301.00SCY
6$15,334$46.07$14,998$563.56+$336.00SCY
7$16,453$46.21$16,098$619.52+$355.00SCY
8$17,651$46.34$17,295$681.69+$356.00SCY
9$18,933$46.46$18,599$750.82+$334.00SCY
10$20,305$46.58$20,022$827.78+$283.00SCY

SCY vs JNJ: Complete Analysis 2026

SCYStock

The Simplify US Small Cap PLUS Income ETF (SCY) seeks capital appreciation and income. An actively managed ETF, it combines equity securities of US small-capitalization companies with an income-generating options overlay. Exposure to equities will be obtained primarily by purchasing one or more representative ETFs. The options overlay will focus on writing short-term spreads on a variety of underlying assets, including equity, fixed income, and commodity indices or ETFs.

Full SCY Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this SCY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SCY vs SCHDSCY vs JEPISCY vs OSCY vs KOSCY vs MAINSCY vs ABBVSCY vs MRKSCY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.